Concordia International Corp. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products and clinical research.
Concordia Pharmaceuticals Inc. of Concordia International Corp. product profile: NILANDRON®
Nilandron tablets contain nilutamide. “In animal studies, nilutamide has demonstrated antiandrogenic activity without other hormonal (estrogen, progesterone, mineralocorticoid, and glucocorticoid) effects.”
Concordia International Corp. is an integrated, specialty healthcare company that focuses on legacy pharmaceutical products, orphan drugs, and medical devices for the diabetic population. It engages in the development of pharmaceutical products and medical devices. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in Oakville, Canada. [Source: MarketWatch]
Company Website: http://concordiarx.com